 |
|
|
| |
Virologic Response to Boceprevir Plus Peginterferon Alfa-2a (40KD) and Ribavirin in Treatment-naive Patients with Chronic Hepatitis C and HCV Genotype 1 Infection: Interim Analysis of Data From the International TriCo Study
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
P. Ferenci,1 R. Flisiak,2 F.A. Caruntu,3 G. Lengyel,4 M. Hohmann,5 F. Tatsch;6 on behalf of the TriCo study investigators
1Department of Internal Medicine III, Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria; 2Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland;3National Institute for Infectious Diseases "Matei Bals", Bucharest, Romania; 42nd Department of Medicine, Semmelweis University, Budapest, Hungary; 5IST GmbH, Mannheim, Germany; 6F. Hoffmann-La Roche Ltd, Basel, Switzerland
|
| |
|
|
|
|
|
